Pharma Foods International Co., Ltd.

Tokyo Stock Exchange 2929.T

Pharma Foods International Co., Ltd. Receivables for the year ending July 31, 2024: USD 28.64 M

Pharma Foods International Co., Ltd. Receivables is USD 28.64 M for the year ending July 31, 2024, a -11.05% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Pharma Foods International Co., Ltd. Receivables for the year ending July 31, 2023 was USD 32.20 M, a -42.21% change year over year.
Pharma Foods International Co., Ltd. Receivables for the year ending July 31, 2022 was USD 55.72 M, a 24.32% change year over year.
Pharma Foods International Co., Ltd. Receivables for the year ending July 31, 2021 was USD 44.82 M, a 112.37% change year over year.
Pharma Foods International Co., Ltd. Receivables for the year ending July 31, 2020 was USD 21.10 M, a 79.59% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Tokyo Stock Exchange: 2929.T

Pharma Foods International Co., Ltd.

CEO	Mr. Mu Jo Kim
IPO Date	June 12, 2006
Location	Japan
Headquarters	1-49 Goryo-Ohara
Employees	642
Sector	Healthcare
Industries Biotechnology Cosmetics Non-Alcoholic Beverages Personal Care Pet Food Pharmaceuticals Plastics Snack Foods

Description

Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Pharma Foods International Co., Ltd. has licensing agreement with Mitsubishi Tanabe Pharma Corporation for a new therapeutic antibody to treat autoimmune diseases. Pharma Foods International Co., Ltd. was founded in 1997 and is based in Kyoto, Japan.

Key trends

Past 5 years